These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24969890)
1. DEPTOR expression negatively correlates with mTORC1 activity and tumor progression in colorectal cancer. Lai EY; Chen ZG; Zhou X; Fan XR; Wang H; Lai PL; Su YC; Zhang BY; Bai XC; Li YF Asian Pac J Cancer Prev; 2014; 15(11):4589-94. PubMed ID: 24969890 [TBL] [Abstract][Full Text] [Related]
2. p65 down-regulates DEPTOR expression in response to LPS stimulation in hepatocytes. Yu X; Jin D; Yu A; Sun J; Chen X; Yang Z Gene; 2016 Sep; 589(1):12-19. PubMed ID: 27179948 [TBL] [Abstract][Full Text] [Related]
3. TGFβ-induced deptor suppression recruits mTORC1 and not mTORC2 to enhance collagen I (α2) gene expression. Das F; Bera A; Ghosh-Choudhury N; Abboud HE; Kasinath BS; Choudhury GG PLoS One; 2014; 9(10):e109608. PubMed ID: 25333702 [TBL] [Abstract][Full Text] [Related]
4. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis. Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358 [TBL] [Abstract][Full Text] [Related]
5. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth. Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma. Pei L; Xie P; Zhou E; Yang Q; Luo Y; Tang Z Mol Med Rep; 2011; 4(5):817-23. PubMed ID: 21643629 [TBL] [Abstract][Full Text] [Related]
8. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer. Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691 [TBL] [Abstract][Full Text] [Related]
9. Autophagy-related genes Raptor, Rictor, and Beclin1 expression and relationship with multidrug resistance in colorectal carcinoma. Shuhua W; Chenbo S; Yangyang L; Xiangqian G; Shuang H; Tangyue L; Dong T Hum Pathol; 2015 Nov; 46(11):1752-9. PubMed ID: 26363527 [TBL] [Abstract][Full Text] [Related]
10. Chemopreventive Effect of Dietary Glutamineon Colitis-Associated Colorectal Cancer Is Associated with Modulation of the DEPTOR/mTOR Signaling Pathway. Tian Y; Wang K; Fan Y; Wang Y; Sun L; Wang L; Wang J; Wang Z; Li J; Ye Y; Ji G Nutrients; 2016 May; 8(5):. PubMed ID: 27144580 [TBL] [Abstract][Full Text] [Related]
11. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes. Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151 [TBL] [Abstract][Full Text] [Related]
12. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252 [TBL] [Abstract][Full Text] [Related]
13. microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression. Maity S; Bera A; Ghosh-Choudhury N; Das F; Kasinath BS; Choudhury GG Exp Cell Res; 2018 Mar; 364(1):5-15. PubMed ID: 29397070 [TBL] [Abstract][Full Text] [Related]
14. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway. Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010 [TBL] [Abstract][Full Text] [Related]
15. p38γ and δ promote heart hypertrophy by targeting the mTOR-inhibitory protein DEPTOR for degradation. González-Terán B; López JA; Rodríguez E; Leiva L; Martínez-Martínez S; Bernal JA; Jiménez-Borreguero LJ; Redondo JM; Vazquez J; Sabio G Nat Commun; 2016 Jan; 7():10477. PubMed ID: 26795633 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression. Qin A; Qian W Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship study of small molecule inhibitors of the DEPTOR-mTOR interaction. Lee J; Shi Y; Vega M; Yang Y; Gera J; Jung ME; Lichtenstein A Bioorg Med Chem Lett; 2017 Oct; 27(20):4714-4724. PubMed ID: 28916338 [TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significances of Beclin1, LC3 and mTOR in colorectal cancer. Wu S; Sun C; Tian D; Li Y; Gao X; He S; Li T Int J Clin Exp Pathol; 2015; 8(4):3882-91. PubMed ID: 26097572 [TBL] [Abstract][Full Text] [Related]
19. Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace. Heimhalt M; Berndt A; Wagstaff J; Anandapadamanaban M; Perisic O; Maslen S; McLaughlin S; Yu CW; Masson GR; Boland A; Ni X; Yamashita K; Murshudov GN; Skehel M; Freund SM; Williams RL Elife; 2021 Sep; 10():. PubMed ID: 34519269 [TBL] [Abstract][Full Text] [Related]
20. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers. Alqurashi N; Gopalan V; Smith RA; Lam AK Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]